245 related articles for article (PubMed ID: 17693159)
1. Tetrahydrobiopterin for patients with phenylketonuria.
Pey AL; Martinez A
Lancet; 2007 Aug; 370(9586):462-3. PubMed ID: 17693159
[No Abstract] [Full Text] [Related]
2. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Blau N; Erlandsen H
Mol Genet Metab; 2004 Jun; 82(2):101-11. PubMed ID: 15171997
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.
Heintz C; Cotton RG; Blau N
Hum Mutat; 2013 Jul; 34(7):927-36. PubMed ID: 23559577
[TBL] [Abstract][Full Text] [Related]
4. [Genotyping and treatment modification in patients with phenylketonuria: an introduction to pharmacogenomics].
Bik-Multanowski M; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):1-3. PubMed ID: 19485247
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of phenylketonuria with tetrahydrobiopterin.
Trefz FK; Aulela-Scholz C; Blau N
Eur J Pediatr; 2001 May; 160(5):315. PubMed ID: 11388602
[No Abstract] [Full Text] [Related]
7. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
[TBL] [Abstract][Full Text] [Related]
8. Sapropterin (Kuvan) for phenylketonuria.
Med Lett Drugs Ther; 2008 Jun; 50(1287):43-4. PubMed ID: 18509266
[No Abstract] [Full Text] [Related]
9. Tetrahydrobiopterin-responsive hyperphenylalaninaemia due to homozygous mutations in the phenylalanine hydroxylase gene.
Blau N; Bernegger C; Trefz FK
Eur J Pediatr; 2003 Mar; 162(3):196. PubMed ID: 12659094
[No Abstract] [Full Text] [Related]
10. Development of a model for assessment of phenylalanine hydroxylase activity in newborns with phenylketonuria receiving tetrahydrobiopterin: a potential for practical implementation.
Bik-Multanowski M; Pietrzyk JJ; Didycz B; Szymczakiewicz-Multanowska A
Mol Genet Metab; 2008 Jul; 94(3):389-90. PubMed ID: 18482855
[No Abstract] [Full Text] [Related]
11. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Kure S; Hou DC; Ohura T; Iwamoto H; Suzuki S; Sugiyama N; Sakamoto O; Fujii K; Matsubara Y; Narisawa K
J Pediatr; 1999 Sep; 135(3):375-8. PubMed ID: 10484807
[TBL] [Abstract][Full Text] [Related]
12. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the regulatory domain of phenylalanine hydroxylase and response to tetrahydrobiopterin.
Wang L; Surendran S; Michals-Matalon K; Bhatia G; Tanskley S; Koch R; Grady J; Tyring SK; Stevens RC; Guttler F; Matalon R
Genet Test; 2007; 11(2):174-8. PubMed ID: 17627389
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype.
Lindner M; Haas D; Mayatepek E; Zschocke J; Burgard P
Mol Genet Metab; 2001 May; 73(1):104-6. PubMed ID: 11350190
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
Dobrowolski SF; Heintz C; Miller T; Ellingson C; Ellingson C; Ozer I; Gökçay G; Baykal T; Thöny B; Demirkol M; Blau N
Mol Genet Metab; 2011 Feb; 102(2):116-21. PubMed ID: 21147011
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin responsiveness in a large series of phenylketonuria patients.
Weglage J; Grenzebach M; von Teeffelen-Heithoff A; Marquardt T; Feldmann R; Denecke J; Gödde D; Koch HG
J Inherit Metab Dis; 2002 Aug; 25(4):321-2. PubMed ID: 12227464
[TBL] [Abstract][Full Text] [Related]
18. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria.
Trefz FK; Belanger-Quintana A
Drugs Today (Barc); 2010 Aug; 46(8):589-600. PubMed ID: 20830319
[TBL] [Abstract][Full Text] [Related]
19. A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
Dobrowolski SF; Borski K; Ellingson CC; Koch R; Levy HL; Naylor EW
J Hum Genet; 2009 Jun; 54(6):335-9. PubMed ID: 19444284
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin and mild phenylketonuria.
Hanley WB
N Engl J Med; 2003 Apr; 348(17):1722-4; author reply 1722-4. PubMed ID: 12715774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
